首页> 外文期刊>Metabolism: Clinical and Experimental >Most of the interleukin 1 receptor antagonist, cathepsin S, macrophage migration inhibitory factor, nerve growth factor, and interleukin 18 release by explants of human adipose tissue is by the non-fat cells, not by the adipocytes.
【24h】

Most of the interleukin 1 receptor antagonist, cathepsin S, macrophage migration inhibitory factor, nerve growth factor, and interleukin 18 release by explants of human adipose tissue is by the non-fat cells, not by the adipocytes.

机译:人脂肪组织外植体释放的大多数白介素1受体拮抗剂,组织蛋白酶S,巨噬细胞迁移抑制因子,神经生长因子和白介素18释放是通过非脂肪细胞而不是脂肪细胞。

获取原文
获取原文并翻译 | 示例
           

摘要

The present studies were designed to compare the relative release of interleukin 1 receptor antagonist (IL-1Ra), cathepsin S, macrophage migration inhibitory factor (MIF), nerve growth factor (NGF), and interleukin 18 (IL-18) by adipocytes as compared with the non-fat cells present in subcutaneous and omental adipose tissue from morbidly obese gastric bypass patients as compared with obese abdominoplasty patients. The release of IL-1Ra, cathepsin S, and MIF by explants of human adipose tissue incubated for 48 hours averaged 6, 9, and 19 pmol/g, respectively, and was far greater than the release of NGF (0.05 pmol/g) or IL-18 (0.006 pmol/g). The release by human adipocytes of IL-1Ra, cathepsin S, and MIF was 0.13, 0.32, and 2.6 pmol/g, respectively, over 48 hours, whereas NGF release was 0.003 and IL-18 0.001 pmol/g. Only the total release of MIF by human adipose tissue explants was enhanced, whereas that of IL-18 was significantly reduced in explants from morbidly obese women. Most of (55%-73%) the release of IL-1Ra, cathepsin S, MIF, NGF, and IL-18 was by the adipose tissue matrix, whereas release by stromal-vascular (SV) cells was 3% to 28% of total release over 48 hours by the adipose tissue matrix, SV cells and adipocytes. The release of NGF by adipocytes was 42%, that of MIF was 27%, and for the other factors 15% or less of release over 48 hours by the adipose tissue matrix, SV cells, and adipocytes. Our results suggest that the non-fat cells in human adipose tissue contribute to most of the release of NGF, IL-18, IL-1Ra, cathepsin S, and MIF seen during primary culture of adipose tissue explants from obese women.
机译:本研究旨在比较脂肪细胞对白介素1受体拮抗剂(IL-1Ra),组织蛋白酶S,巨噬细胞迁移抑制因子(MIF),神经生长因子(NGF)和白介素18(IL-18)的相对释放。与肥胖的腹部整形手术患者相比,病态肥胖的胃旁路手术患者的皮下和网膜脂肪组织中存在的非脂肪细胞的比例。孵育48小时的人脂肪组织外植体释放的IL-1Ra,组织蛋白酶S和MIF分别平均为6、9和19 pmol / g,远大于NGF的释放量(0.05 pmol / g)。或IL-18(0.006 pmol / g)。在48小时内,人脂肪细胞释放的IL-1Ra,组织蛋白酶S和MIF分别为0.13、0.32和2.6 pmol / g,而NGF的释放为0.003和IL-18 0.001 pmol / g。仅病态肥胖妇女的外植体中,人脂肪组织外植体的MIF释放总量得以提高,而IL-18的释放显着降低。 IL-1Ra,组织蛋白酶S,MIF,NGF和IL-18的大部分释放(55%-73%)是通过脂肪组织基质释放的,而基质血管(SV)细胞的释放是3%至28%脂肪组织基质,SV细胞和脂肪细胞在48小时内的总释放量。脂肪细胞的NGF释放率为42%,MIF的释放为27%,其他因素在48小时内脂肪组织基质,SV细胞和脂肪细胞的释放为15%或更少。我们的结果表明,在肥胖妇女的脂肪组织外植体原代培养过程中,人脂肪组织中的非脂肪细胞促成NGF,IL-18,IL-1Ra,组织蛋白酶S和MIF的大部分释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号